COVID-19 Blood Flow Changes May Be Reason for ‘Brain Fog,’ Depression

Lack of oxygen, increased inflammation affects serotonin levels in brain

Rockville, Md. (February 24, 2021)—A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a role in mood changes and cognitive difficulties that people with the disease face during illness and recovery. The review is published in Physiological Reports.

COVID-19, the disease caused by the SARS CoV-2 virus, may cause a wide range of symptoms ranging from lack of taste and smell, muscle weakness and fatigue to acute respiratory distress syndrome and multiple organ failure. Changes in blood flow and microscopic clots in the body’s smallest blood vessels can also affect people with the disease. “While most symptoms disappear over the weeks and months following the infection, the extent of long-term COVID-19 [complications] remains unclear,” the authors of the review wrote.

One cluster of symptoms people with COVID-19 have experienced—even after active infection has passed—is cognitive or mood impairment. This may include memory problems, depression, anxiety and the inability to focus or concentrate, which is called “brain fog.” Previous research has found that people with a diagnosis of mild cognitive impairment or Alzheimer’s disease show “widespread cerebral microvascular flow disturbances.” The current review explains that in people with COVID-19, a shortened blood flow transit time in the capillaries limits the amount of oxygen that can be delivered to the lungs and brain.

Low oxygen levels and the increase in inflammatory cytokines—proteins involved in immune system signaling—that occur with COVID-19 can also affect serotonin levels. Serotonin is a neurotransmitter the brain produces to regulate mood. Low levels of serotonin have been linked to anxiety and lowered mood. Oxygen is crucial for the production of serotonin, and research suggests cytokines reduce serotonin levels. “These mechanisms could affect cognitive functions and quality of life for COVID-19 patients,” the reviewers wrote.

Other findings discussed in the review include:

• The recovery of COVID-19 patients may rely on the restoration of normal blood flow through the body’s smallest blood vessels.
• Development of new blood vessels in COVID-19 may form shunts for blood delivery through the lungs and contribute to poor blood oxygenation.

Read the full article, “SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation,” published in Physiological Reports.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or call 301.634.7314. Find more research highlights in our Newsroom.

Physiology is a broad area of scientific inquiry that focuses on how molecules, cells, tissues and organs function in health and disease. The American Physiological Society connects a global, multidisciplinary community of more than 10,000 biomedical scientists and educators as part of its mission to advance scientific discovery, understand life and improve health. The Society drives collaboration and spotlights scientific discoveries through its 16 scholarly journals and programming that support researchers and educators in their work.